Sotera Health Company (SHC)
SHC Stock Price Chart
Explore Sotera Health Company interactive price chart. Choose custom timeframes to analyze SHC price movements and trends.
SHC Company Profile
Discover essential business fundamentals and corporate details for Sotera Health Company (SHC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
20 Nov 2020
Employees
3.00K
Website
https://soterahealth.comCEO
Michael B. Petras Jr.
Description
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
SHC Financial Timeline
Browse a chronological timeline of Sotera Health Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Apr 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 4 Nov 2025
EPS estimate is $0.22, while revenue estimate is $303.63M.
Earnings released on 8 Aug 2025
EPS came in at $0.20 surpassing the estimated $0.17 by +17.65%, while revenue for the quarter reached $294.34M , missing expectations by -3.49%.
Earnings released on 1 May 2025
EPS came in at $0.14 surpassing the estimated $0.12 by +16.67%, while revenue for the quarter reached $254.52M , missing expectations by -8.10%.
Earnings released on 27 Feb 2025
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $290.20M , beating expectations by +11.75%.
Earnings released on 5 Nov 2024
EPS came in at $0.17 falling short of the estimated $0.19 by -10.53%, while revenue for the quarter reached $285.47M , missing expectations by -2.18%.
Earnings released on 5 Aug 2024
EPS came in at $0.19 surpassing the estimated $0.17 by +11.76%, while revenue for the quarter reached $276.59M , beating expectations by +3.81%.
Earnings released on 2 May 2024
EPS came in at $0.13 falling short of the estimated $0.14 by -7.14%, while revenue for the quarter reached $248.18M , beating expectations by +1.48%.
Earnings released on 27 Feb 2024
EPS came in at $0.26 matching the estimated $0.26, while revenue for the quarter reached $310.24M , beating expectations by +2.68%.
Earnings released on 1 Nov 2023
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $263.18M , missing expectations by -12.00%.
Earnings released on 3 Aug 2023
EPS came in at $0.21 surpassing the estimated $0.18 by +16.67%, while revenue for the quarter reached $255.28M , missing expectations by -1.41%.
Earnings released on 3 May 2023
EPS came in at $0.13 falling short of the estimated $0.14 by -7.14%, while revenue for the quarter reached $220.59M , missing expectations by -0.20%.
Earnings released on 28 Feb 2023
EPS came in at $0.25 surpassing the estimated $0.22 by +13.64%, while revenue for the quarter reached $251.59M , beating expectations by +1.67%.
Earnings released on 2 Nov 2022
EPS came in at $0.23 surpassing the estimated $0.22 by +4.55%, while revenue for the quarter reached $248.70M , beating expectations by +0.20%.
Earnings released on 4 Aug 2022
EPS came in at $0.27 surpassing the estimated $0.24 by +12.50%, while revenue for the quarter reached $266.64M , beating expectations by +4.03%.
Earnings released on 5 May 2022
EPS came in at $0.22 surpassing the estimated $0.19 by +15.79%, while revenue for the quarter reached $236.75M , beating expectations by +2.86%.
Earnings released on 1 Mar 2022
EPS came in at $0.23 surpassing the estimated $0.22 by +4.55%, while revenue for the quarter reached $241.25M , beating expectations by +2.06%.
Earnings released on 10 Nov 2021
EPS came in at $0.21 surpassing the estimated $0.20 by +5.00%, while revenue for the quarter reached $226.16M , beating expectations by +5.56%.
Earnings released on 12 Aug 2021
EPS came in at $0.26 surpassing the estimated $0.21 by +23.81%, while revenue for the quarter reached $251.92M , meeting expectations.
Earnings released on 13 May 2021
EPS came in at $0.18 surpassing the estimated $0.16 by +12.50%, while revenue for the quarter reached $212.15M , beating expectations by +14.29%.
Earnings released on 9 Mar 2021
EPS came in at $0.09 surpassing the estimated $0.08 by +12.50%, while revenue for the quarter reached $216.85M .
Earnings released on 19 Nov 2020
EPS came in at $0.00 , while revenue for the quarter reached $200.03M .
SHC Stock Performance
Access detailed SHC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.